1 Study Coverage
    1.1 Human Insulin Drugs And Delivery Devices Product Introduction
    1.2 Market by Type
        1.2.1 Global Human Insulin Drugs And Delivery Devices Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Insulin Pumps
        1.2.3 Insulin Pens
        1.2.4 Insulin Syringes
        1.2.5 Basal or Long Acting Insulins
        1.2.6 Bolus or Fast-Acting Insulins
    1.3 Market by Application
        1.3.1 Global Human Insulin Drugs And Delivery Devices Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Hospital
        1.3.3 Household
    1.4 Study Objectives
    1.5 Years Considered
2 Executive Summary
    2.1 Global Human Insulin Drugs And Delivery Devices Sales Estimates and Forecasts 2017-2028
    2.2 Global Human Insulin Drugs And Delivery Devices Revenue Estimates and Forecasts 2017-2028
    2.3 Global Human Insulin Drugs And Delivery Devices Revenue by Region: 2017 VS 2021 VS 2028
    2.4 Global Human Insulin Drugs And Delivery Devices Sales by Region
        2.4.1 Global Human Insulin Drugs And Delivery Devices Sales by Region (2017-2022)
        2.4.2 Global Sales Human Insulin Drugs And Delivery Devices by Region (2023-2028)
    2.5 Global Human Insulin Drugs And Delivery Devices Revenue by Region
        2.5.1 Global Human Insulin Drugs And Delivery Devices Revenue by Region (2017-2022)
        2.5.2 Global Human Insulin Drugs And Delivery Devices Revenue by Region (2023-2028)
    2.6 North America
    2.7 Europe
    2.8 Asia-Pacific
    2.9 Latin America
    2.10 Middle East & Africa
3 Competition by Manufacturers
    3.1 Global Human Insulin Drugs And Delivery Devices Sales by Manufacturers
        3.1.1 Global Top Human Insulin Drugs And Delivery Devices Manufacturers by Sales (2017-2022)
        3.1.2 Global Human Insulin Drugs And Delivery Devices Sales Market Share by Manufacturers (2017-2022)
        3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Human Insulin Drugs And Delivery Devices in 2021
    3.2 Global Human Insulin Drugs And Delivery Devices Revenue by Manufacturers
        3.2.1 Global Human Insulin Drugs And Delivery Devices Revenue by Manufacturers (2017-2022)
        3.2.2 Global Human Insulin Drugs And Delivery Devices Revenue Market Share by Manufacturers (2017-2022)
        3.2.3 Global Top 10 and Top 5 Companies by Human Insulin Drugs And Delivery Devices Revenue in 2021
    3.3 Global Human Insulin Drugs And Delivery Devices Sales Price by Manufacturers (2017-2022)
    3.4 Analysis of Competitive Landscape
        3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Human Insulin Drugs And Delivery Devices Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
        3.4.3 Global Human Insulin Drugs And Delivery Devices Manufacturers Geographical Distribution
    3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
    4.1 Global Human Insulin Drugs And Delivery Devices Sales by Type
        4.1.1 Global Human Insulin Drugs And Delivery Devices Historical Sales by Type (2017-2022)
        4.1.2 Global Human Insulin Drugs And Delivery Devices Forecasted Sales by Type (2023-2028)
        4.1.3 Global Human Insulin Drugs And Delivery Devices Sales Market Share by Type (2017-2028)
    4.2 Global Human Insulin Drugs And Delivery Devices Revenue by Type
        4.2.1 Global Human Insulin Drugs And Delivery Devices Historical Revenue by Type (2017-2022)
        4.2.2 Global Human Insulin Drugs And Delivery Devices Forecasted Revenue by Type (2023-2028)
        4.2.3 Global Human Insulin Drugs And Delivery Devices Revenue Market Share by Type (2017-2028)
    4.3 Global Human Insulin Drugs And Delivery Devices Price by Type
        4.3.1 Global Human Insulin Drugs And Delivery Devices Price by Type (2017-2022)
        4.3.2 Global Human Insulin Drugs And Delivery Devices Price Forecast by Type (2023-2028)
5 Market Size by Application
    5.1 Global Human Insulin Drugs And Delivery Devices Sales by Application
        5.1.1 Global Human Insulin Drugs And Delivery Devices Historical Sales by Application (2017-2022)
        5.1.2 Global Human Insulin Drugs And Delivery Devices Forecasted Sales by Application (2023-2028)
        5.1.3 Global Human Insulin Drugs And Delivery Devices Sales Market Share by Application (2017-2028)
    5.2 Global Human Insulin Drugs And Delivery Devices Revenue by Application
        5.2.1 Global Human Insulin Drugs And Delivery Devices Historical Revenue by Application (2017-2022)
        5.2.2 Global Human Insulin Drugs And Delivery Devices Forecasted Revenue by Application (2023-2028)
        5.2.3 Global Human Insulin Drugs And Delivery Devices Revenue Market Share by Application (2017-2028)
    5.3 Global Human Insulin Drugs And Delivery Devices Price by Application
        5.3.1 Global Human Insulin Drugs And Delivery Devices Price by Application (2017-2022)
        5.3.2 Global Human Insulin Drugs And Delivery Devices Price Forecast by Application (2023-2028)
6 North America
    6.1 North America Human Insulin Drugs And Delivery Devices Market Size by Type
        6.1.1 North America Human Insulin Drugs And Delivery Devices Sales by Type (2017-2028)
        6.1.2 North America Human Insulin Drugs And Delivery Devices Revenue by Type (2017-2028)
    6.2 North America Human Insulin Drugs And Delivery Devices Market Size by Application
        6.2.1 North America Human Insulin Drugs And Delivery Devices Sales by Application (2017-2028)
        6.2.2 North America Human Insulin Drugs And Delivery Devices Revenue by Application (2017-2028)
    6.3 North America Human Insulin Drugs And Delivery Devices Market Size by Country
        6.3.1 North America Human Insulin Drugs And Delivery Devices Sales by Country (2017-2028)
        6.3.2 North America Human Insulin Drugs And Delivery Devices Revenue by Country (2017-2028)
        6.3.3 U.S.
        6.3.4 Canada
7 Europe
    7.1 Europe Human Insulin Drugs And Delivery Devices Market Size by Type
        7.1.1 Europe Human Insulin Drugs And Delivery Devices Sales by Type (2017-2028)
        7.1.2 Europe Human Insulin Drugs And Delivery Devices Revenue by Type (2017-2028)
    7.2 Europe Human Insulin Drugs And Delivery Devices Market Size by Application
        7.2.1 Europe Human Insulin Drugs And Delivery Devices Sales by Application (2017-2028)
        7.2.2 Europe Human Insulin Drugs And Delivery Devices Revenue by Application (2017-2028)
    7.3 Europe Human Insulin Drugs And Delivery Devices Market Size by Country
        7.3.1 Europe Human Insulin Drugs And Delivery Devices Sales by Country (2017-2028)
        7.3.2 Europe Human Insulin Drugs And Delivery Devices Revenue by Country (2017-2028)
        7.3.3 Germany
        7.3.4 France
        7.3.5 U.K.
        7.3.6 Italy
        7.3.7 Russia
8 Asia Pacific
    8.1 Asia Pacific Human Insulin Drugs And Delivery Devices Market Size by Type
        8.1.1 Asia Pacific Human Insulin Drugs And Delivery Devices Sales by Type (2017-2028)
        8.1.2 Asia Pacific Human Insulin Drugs And Delivery Devices Revenue by Type (2017-2028)
    8.2 Asia Pacific Human Insulin Drugs And Delivery Devices Market Size by Application
        8.2.1 Asia Pacific Human Insulin Drugs And Delivery Devices Sales by Application (2017-2028)
        8.2.2 Asia Pacific Human Insulin Drugs And Delivery Devices Revenue by Application (2017-2028)
    8.3 Asia Pacific Human Insulin Drugs And Delivery Devices Market Size by Region
        8.3.1 Asia Pacific Human Insulin Drugs And Delivery Devices Sales by Region (2017-2028)
        8.3.2 Asia Pacific Human Insulin Drugs And Delivery Devices Revenue by Region (2017-2028)
        8.3.3 China
        8.3.4 Japan
        8.3.5 South Korea
        8.3.6 India
        8.3.7 Australia
        8.3.8 Taiwan
        8.3.9 Indonesia
        8.3.10 Thailand
        8.3.11 Malaysia
        8.3.12 Philippines
9 Latin America
    9.1 Latin America Human Insulin Drugs And Delivery Devices Market Size by Type
        9.1.1 Latin America Human Insulin Drugs And Delivery Devices Sales by Type (2017-2028)
        9.1.2 Latin America Human Insulin Drugs And Delivery Devices Revenue by Type (2017-2028)
    9.2 Latin America Human Insulin Drugs And Delivery Devices Market Size by Application
        9.2.1 Latin America Human Insulin Drugs And Delivery Devices Sales by Application (2017-2028)
        9.2.2 Latin America Human Insulin Drugs And Delivery Devices Revenue by Application (2017-2028)
    9.3 Latin America Human Insulin Drugs And Delivery Devices Market Size by Country
        9.3.1 Latin America Human Insulin Drugs And Delivery Devices Sales by Country (2017-2028)
        9.3.2 Latin America Human Insulin Drugs And Delivery Devices Revenue by Country (2017-2028)
        9.3.3 Mexico
        9.3.4 Brazil
        9.3.5 Argentina
10 Middle East and Africa
    10.1 Middle East and Africa Human Insulin Drugs And Delivery Devices Market Size by Type
        10.1.1 Middle East and Africa Human Insulin Drugs And Delivery Devices Sales by Type (2017-2028)
        10.1.2 Middle East and Africa Human Insulin Drugs And Delivery Devices Revenue by Type (2017-2028)
    10.2 Middle East and Africa Human Insulin Drugs And Delivery Devices Market Size by Application
        10.2.1 Middle East and Africa Human Insulin Drugs And Delivery Devices Sales by Application (2017-2028)
        10.2.2 Middle East and Africa Human Insulin Drugs And Delivery Devices Revenue by Application (2017-2028)
    10.3 Middle East and Africa Human Insulin Drugs And Delivery Devices Market Size by Country
        10.3.1 Middle East and Africa Human Insulin Drugs And Delivery Devices Sales by Country (2017-2028)
        10.3.2 Middle East and Africa Human Insulin Drugs And Delivery Devices Revenue by Country (2017-2028)
        10.3.3 Turkey
        10.3.4 Saudi Arabia
11 Company Profiles
    11.1 Novo Nordisk
        11.1.1 Novo Nordisk Corporation Information
        11.1.2 Novo Nordisk Overview
        11.1.3 Novo Nordisk Human Insulin Drugs And Delivery Devices Sales, Price, Revenue and Gross Margin (2017-2022)
        11.1.4 Novo Nordisk Human Insulin Drugs And Delivery Devices Product Model Numbers, Pictures, Descriptions and Specifications
        11.1.5 Novo Nordisk Recent Developments
    11.2 Sanofi Aventis
        11.2.1 Sanofi Aventis Corporation Information
        11.2.2 Sanofi Aventis Overview
        11.2.3 Sanofi Aventis Human Insulin Drugs And Delivery Devices Sales, Price, Revenue and Gross Margin (2017-2022)
        11.2.4 Sanofi Aventis Human Insulin Drugs And Delivery Devices Product Model Numbers, Pictures, Descriptions and Specifications
        11.2.5 Sanofi Aventis Recent Developments
    11.3 Eli Lilly
        11.3.1 Eli Lilly Corporation Information
        11.3.2 Eli Lilly Overview
        11.3.3 Eli Lilly Human Insulin Drugs And Delivery Devices Sales, Price, Revenue and Gross Margin (2017-2022)
        11.3.4 Eli Lilly Human Insulin Drugs And Delivery Devices Product Model Numbers, Pictures, Descriptions and Specifications
        11.3.5 Eli Lilly Recent Developments
    11.4 Biocon
        11.4.1 Biocon Corporation Information
        11.4.2 Biocon Overview
        11.4.3 Biocon Human Insulin Drugs And Delivery Devices Sales, Price, Revenue and Gross Margin (2017-2022)
        11.4.4 Biocon Human Insulin Drugs And Delivery Devices Product Model Numbers, Pictures, Descriptions and Specifications
        11.4.5 Biocon Recent Developments
    11.5 Julphar
        11.5.1 Julphar Corporation Information
        11.5.2 Julphar Overview
        11.5.3 Julphar Human Insulin Drugs And Delivery Devices Sales, Price, Revenue and Gross Margin (2017-2022)
        11.5.4 Julphar Human Insulin Drugs And Delivery Devices Product Model Numbers, Pictures, Descriptions and Specifications
        11.5.5 Julphar Recent Developments
    11.6 Exir
        11.6.1 Exir Corporation Information
        11.6.2 Exir Overview
        11.6.3 Exir Human Insulin Drugs And Delivery Devices Sales, Price, Revenue and Gross Margin (2017-2022)
        11.6.4 Exir Human Insulin Drugs And Delivery Devices Product Model Numbers, Pictures, Descriptions and Specifications
        11.6.5 Exir Recent Developments
    11.7 Medtronic
        11.7.1 Medtronic Corporation Information
        11.7.2 Medtronic Overview
        11.7.3 Medtronic Human Insulin Drugs And Delivery Devices Sales, Price, Revenue and Gross Margin (2017-2022)
        11.7.4 Medtronic Human Insulin Drugs And Delivery Devices Product Model Numbers, Pictures, Descriptions and Specifications
        11.7.5 Medtronic Recent Developments
    11.8 Insulet
        11.8.1 Insulet Corporation Information
        11.8.2 Insulet Overview
        11.8.3 Insulet Human Insulin Drugs And Delivery Devices Sales, Price, Revenue and Gross Margin (2017-2022)
        11.8.4 Insulet Human Insulin Drugs And Delivery Devices Product Model Numbers, Pictures, Descriptions and Specifications
        11.8.5 Insulet Recent Developments
    11.9 Ypsomed
        11.9.1 Ypsomed Corporation Information
        11.9.2 Ypsomed Overview
        11.9.3 Ypsomed Human Insulin Drugs And Delivery Devices Sales, Price, Revenue and Gross Margin (2017-2022)
        11.9.4 Ypsomed Human Insulin Drugs And Delivery Devices Product Model Numbers, Pictures, Descriptions and Specifications
        11.9.5 Ypsomed Recent Developments
    11.10 Becton Dickinson
        11.10.1 Becton Dickinson Corporation Information
        11.10.2 Becton Dickinson Overview
        11.10.3 Becton Dickinson Human Insulin Drugs And Delivery Devices Sales, Price, Revenue and Gross Margin (2017-2022)
        11.10.4 Becton Dickinson Human Insulin Drugs And Delivery Devices Product Model Numbers, Pictures, Descriptions and Specifications
        11.10.5 Becton Dickinson Recent Developments
12 Industry Chain and Sales Channels Analysis
    12.1 Human Insulin Drugs And Delivery Devices Industry Chain Analysis
    12.2 Human Insulin Drugs And Delivery Devices Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 Human Insulin Drugs And Delivery Devices Production Mode & Process
    12.4 Human Insulin Drugs And Delivery Devices Sales and Marketing
        12.4.1 Human Insulin Drugs And Delivery Devices Sales Channels
        12.4.2 Human Insulin Drugs And Delivery Devices Distributors
    12.5 Human Insulin Drugs And Delivery Devices Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
    13.1 Human Insulin Drugs And Delivery Devices Industry Trends
    13.2 Human Insulin Drugs And Delivery Devices Market Drivers
    13.3 Human Insulin Drugs And Delivery Devices Market Challenges
    13.4 Human Insulin Drugs And Delivery Devices Market Restraints
14 Key Findings in The Global Human Insulin Drugs And Delivery Devices Study
15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer
                  
              

                

                 
List of Tables
    Table 1. Global Human Insulin Drugs And Delivery Devices Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of Insulin Pumps
    Table 3. Major Manufacturers of Insulin Pens
    Table 4. Major Manufacturers of Insulin Syringes
    Table 5. Major Manufacturers of Basal or Long Acting Insulins
    Table 6. Major Manufacturers of Bolus or Fast-Acting Insulins
    Table 7. Global Human Insulin Drugs And Delivery Devices Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
    Table 8. Global Human Insulin Drugs And Delivery Devices Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 9. Global Human Insulin Drugs And Delivery Devices Sales by Region (2017-2022) & (K Units)
    Table 10. Global Human Insulin Drugs And Delivery Devices Sales Market Share by Region (2017-2022)
    Table 11. Global Human Insulin Drugs And Delivery Devices Sales by Region (2023-2028) & (K Units)
    Table 12. Global Human Insulin Drugs And Delivery Devices Sales Market Share by Region (2023-2028)
    Table 13. Global Human Insulin Drugs And Delivery Devices Revenue by Region (2017-2022) & (US$ Million)
    Table 14. Global Human Insulin Drugs And Delivery Devices Revenue Market Share by Region (2017-2022)
    Table 15. Global Human Insulin Drugs And Delivery Devices Revenue by Region (2023-2028) & (US$ Million)
    Table 16. Global Human Insulin Drugs And Delivery Devices Revenue Market Share by Region (2023-2028)
    Table 17. Global Human Insulin Drugs And Delivery Devices Sales by Manufacturers (2017-2022) & (K Units)
    Table 18. Global Human Insulin Drugs And Delivery Devices Sales Share by Manufacturers (2017-2022)
    Table 19. Global Human Insulin Drugs And Delivery Devices Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 20. Global Human Insulin Drugs And Delivery Devices Revenue Share by Manufacturers (2017-2022)
    Table 21. Human Insulin Drugs And Delivery Devices Price by Manufacturers (2017-2022) &(USD/Unit)
    Table 22. Global Human Insulin Drugs And Delivery Devices Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 23. Global Human Insulin Drugs And Delivery Devices by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Insulin Drugs And Delivery Devices as of 2021)
    Table 24. Human Insulin Drugs And Delivery Devices Manufacturing Base Distribution and Headquarters
    Table 25. Manufacturers Human Insulin Drugs And Delivery Devices Product Offered
    Table 26. Date of Manufacturers Enter into Human Insulin Drugs And Delivery Devices Market
    Table 27. Mergers & Acquisitions, Expansion Plans
    Table 28. Global Human Insulin Drugs And Delivery Devices Sales by Type (2017-2022) & (K Units)
    Table 29. Global Human Insulin Drugs And Delivery Devices Sales by Type (2023-2028) & (K Units)
    Table 30. Global Human Insulin Drugs And Delivery Devices Sales Share by Type (2017-2022)
    Table 31. Global Human Insulin Drugs And Delivery Devices Sales Share by Type (2023-2028)
    Table 32. Global Human Insulin Drugs And Delivery Devices Revenue by Type (2017-2022) & (US$ Million)
    Table 33. Global Human Insulin Drugs And Delivery Devices Revenue by Type (2023-2028) & (US$ Million)
    Table 34. Global Human Insulin Drugs And Delivery Devices Revenue Share by Type (2017-2022)
    Table 35. Global Human Insulin Drugs And Delivery Devices Revenue Share by Type (2023-2028)
    Table 36. Human Insulin Drugs And Delivery Devices Price by Type (2017-2022) & (USD/Unit)
    Table 37. Global Human Insulin Drugs And Delivery Devices Price Forecast by Type (2023-2028) & (USD/Unit)
    Table 38. Global Human Insulin Drugs And Delivery Devices Sales by Application (2017-2022) & (K Units)
    Table 39. Global Human Insulin Drugs And Delivery Devices Sales by Application (2023-2028) & (K Units)
    Table 40. Global Human Insulin Drugs And Delivery Devices Sales Share by Application (2017-2022)
    Table 41. Global Human Insulin Drugs And Delivery Devices Sales Share by Application (2023-2028)
    Table 42. Global Human Insulin Drugs And Delivery Devices Revenue by Application (2017-2022) & (US$ Million)
    Table 43. Global Human Insulin Drugs And Delivery Devices Revenue by Application (2023-2028) & (US$ Million)
    Table 44. Global Human Insulin Drugs And Delivery Devices Revenue Share by Application (2017-2022)
    Table 45. Global Human Insulin Drugs And Delivery Devices Revenue Share by Application (2023-2028)
    Table 46. Human Insulin Drugs And Delivery Devices Price by Application (2017-2022) & (USD/Unit)
    Table 47. Global Human Insulin Drugs And Delivery Devices Price Forecast by Application (2023-2028) & (USD/Unit)
    Table 48. North America Human Insulin Drugs And Delivery Devices Sales by Type (2017-2022) & (K Units)
    Table 49. North America Human Insulin Drugs And Delivery Devices Sales by Type (2023-2028) & (K Units)
    Table 50. North America Human Insulin Drugs And Delivery Devices Revenue by Type (2017-2022) & (US$ Million)
    Table 51. North America Human Insulin Drugs And Delivery Devices Revenue by Type (2023-2028) & (US$ Million)
    Table 52. North America Human Insulin Drugs And Delivery Devices Sales by Application (2017-2022) & (K Units)
    Table 53. North America Human Insulin Drugs And Delivery Devices Sales by Application (2023-2028) & (K Units)
    Table 54. North America Human Insulin Drugs And Delivery Devices Revenue by Application (2017-2022) & (US$ Million)
    Table 55. North America Human Insulin Drugs And Delivery Devices Revenue by Application (2023-2028) & (US$ Million)
    Table 56. North America Human Insulin Drugs And Delivery Devices Sales by Country (2017-2022) & (K Units)
    Table 57. North America Human Insulin Drugs And Delivery Devices Sales by Country (2023-2028) & (K Units)
    Table 58. North America Human Insulin Drugs And Delivery Devices Revenue by Country (2017-2022) & (US$ Million)
    Table 59. North America Human Insulin Drugs And Delivery Devices Revenue by Country (2023-2028) & (US$ Million)
    Table 60. Europe Human Insulin Drugs And Delivery Devices Sales by Type (2017-2022) & (K Units)
    Table 61. Europe Human Insulin Drugs And Delivery Devices Sales by Type (2023-2028) & (K Units)
    Table 62. Europe Human Insulin Drugs And Delivery Devices Revenue by Type (2017-2022) & (US$ Million)
    Table 63. Europe Human Insulin Drugs And Delivery Devices Revenue by Type (2023-2028) & (US$ Million)
    Table 64. Europe Human Insulin Drugs And Delivery Devices Sales by Application (2017-2022) & (K Units)
    Table 65. Europe Human Insulin Drugs And Delivery Devices Sales by Application (2023-2028) & (K Units)
    Table 66. Europe Human Insulin Drugs And Delivery Devices Revenue by Application (2017-2022) & (US$ Million)
    Table 67. Europe Human Insulin Drugs And Delivery Devices Revenue by Application (2023-2028) & (US$ Million)
    Table 68. Europe Human Insulin Drugs And Delivery Devices Sales by Country (2017-2022) & (K Units)
    Table 69. Europe Human Insulin Drugs And Delivery Devices Sales by Country (2023-2028) & (K Units)
    Table 70. Europe Human Insulin Drugs And Delivery Devices Revenue by Country (2017-2022) & (US$ Million)
    Table 71. Europe Human Insulin Drugs And Delivery Devices Revenue by Country (2023-2028) & (US$ Million)
    Table 72. Asia Pacific Human Insulin Drugs And Delivery Devices Sales by Type (2017-2022) & (K Units)
    Table 73. Asia Pacific Human Insulin Drugs And Delivery Devices Sales by Type (2023-2028) & (K Units)
    Table 74. Asia Pacific Human Insulin Drugs And Delivery Devices Revenue by Type (2017-2022) & (US$ Million)
    Table 75. Asia Pacific Human Insulin Drugs And Delivery Devices Revenue by Type (2023-2028) & (US$ Million)
    Table 76. Asia Pacific Human Insulin Drugs And Delivery Devices Sales by Application (2017-2022) & (K Units)
    Table 77. Asia Pacific Human Insulin Drugs And Delivery Devices Sales by Application (2023-2028) & (K Units)
    Table 78. Asia Pacific Human Insulin Drugs And Delivery Devices Revenue by Application (2017-2022) & (US$ Million)
    Table 79. Asia Pacific Human Insulin Drugs And Delivery Devices Revenue by Application (2023-2028) & (US$ Million)
    Table 80. Asia Pacific Human Insulin Drugs And Delivery Devices Sales by Region (2017-2022) & (K Units)
    Table 81. Asia Pacific Human Insulin Drugs And Delivery Devices Sales by Region (2023-2028) & (K Units)
    Table 82. Asia Pacific Human Insulin Drugs And Delivery Devices Revenue by Region (2017-2022) & (US$ Million)
    Table 83. Asia Pacific Human Insulin Drugs And Delivery Devices Revenue by Region (2023-2028) & (US$ Million)
    Table 84. Latin America Human Insulin Drugs And Delivery Devices Sales by Type (2017-2022) & (K Units)
    Table 85. Latin America Human Insulin Drugs And Delivery Devices Sales by Type (2023-2028) & (K Units)
    Table 86. Latin America Human Insulin Drugs And Delivery Devices Revenue by Type (2017-2022) & (US$ Million)
    Table 87. Latin America Human Insulin Drugs And Delivery Devices Revenue by Type (2023-2028) & (US$ Million)
    Table 88. Latin America Human Insulin Drugs And Delivery Devices Sales by Application (2017-2022) & (K Units)
    Table 89. Latin America Human Insulin Drugs And Delivery Devices Sales by Application (2023-2028) & (K Units)
    Table 90. Latin America Human Insulin Drugs And Delivery Devices Revenue by Application (2017-2022) & (US$ Million)
    Table 91. Latin America Human Insulin Drugs And Delivery Devices Revenue by Application (2023-2028) & (US$ Million)
    Table 92. Latin America Human Insulin Drugs And Delivery Devices Sales by Country (2017-2022) & (K Units)
    Table 93. Latin America Human Insulin Drugs And Delivery Devices Sales by Country (2023-2028) & (K Units)
    Table 94. Latin America Human Insulin Drugs And Delivery Devices Revenue by Country (2017-2022) & (US$ Million)
    Table 95. Latin America Human Insulin Drugs And Delivery Devices Revenue by Country (2023-2028) & (US$ Million)
    Table 96. Middle East and Africa Human Insulin Drugs And Delivery Devices Sales by Type (2017-2022) & (K Units)
    Table 97. Middle East and Africa Human Insulin Drugs And Delivery Devices Sales by Type (2023-2028) & (K Units)
    Table 98. Middle East and Africa Human Insulin Drugs And Delivery Devices Revenue by Type (2017-2022) & (US$ Million)
    Table 99. Middle East and Africa Human Insulin Drugs And Delivery Devices Revenue by Type (2023-2028) & (US$ Million)
    Table 100. Middle East and Africa Human Insulin Drugs And Delivery Devices Sales by Application (2017-2022) & (K Units)
    Table 101. Middle East and Africa Human Insulin Drugs And Delivery Devices Sales by Application (2023-2028) & (K Units)
    Table 102. Middle East and Africa Human Insulin Drugs And Delivery Devices Revenue by Application (2017-2022) & (US$ Million)
    Table 103. Middle East and Africa Human Insulin Drugs And Delivery Devices Revenue by Application (2023-2028) & (US$ Million)
    Table 104. Middle East and Africa Human Insulin Drugs And Delivery Devices Sales by Country (2017-2022) & (K Units)
    Table 105. Middle East and Africa Human Insulin Drugs And Delivery Devices Sales by Country (2023-2028) & (K Units)
    Table 106. Middle East and Africa Human Insulin Drugs And Delivery Devices Revenue by Country (2017-2022) & (US$ Million)
    Table 107. Middle East and Africa Human Insulin Drugs And Delivery Devices Revenue by Country (2023-2028) & (US$ Million)
    Table 108. Novo Nordisk Corporation Information
    Table 109. Novo Nordisk Description and Major Businesses
    Table 110. Novo Nordisk Human Insulin Drugs And Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 111. Novo Nordisk Human Insulin Drugs And Delivery Devices Product Model Numbers, Pictures, Descriptions and Specifications
    Table 112. Novo Nordisk Recent Developments
    Table 113. Sanofi Aventis Corporation Information
    Table 114. Sanofi Aventis Description and Major Businesses
    Table 115. Sanofi Aventis Human Insulin Drugs And Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 116. Sanofi Aventis Human Insulin Drugs And Delivery Devices Product Model Numbers, Pictures, Descriptions and Specifications
    Table 117. Sanofi Aventis Recent Developments
    Table 118. Eli Lilly Corporation Information
    Table 119. Eli Lilly Description and Major Businesses
    Table 120. Eli Lilly Human Insulin Drugs And Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 121. Eli Lilly Human Insulin Drugs And Delivery Devices Product Model Numbers, Pictures, Descriptions and Specifications
    Table 122. Eli Lilly Recent Developments
    Table 123. Biocon Corporation Information
    Table 124. Biocon Description and Major Businesses
    Table 125. Biocon Human Insulin Drugs And Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 126. Biocon Human Insulin Drugs And Delivery Devices Product Model Numbers, Pictures, Descriptions and Specifications
    Table 127. Biocon Recent Developments
    Table 128. Julphar Corporation Information
    Table 129. Julphar Description and Major Businesses
    Table 130. Julphar Human Insulin Drugs And Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 131. Julphar Human Insulin Drugs And Delivery Devices Product Model Numbers, Pictures, Descriptions and Specifications
    Table 132. Julphar Recent Developments
    Table 133. Exir Corporation Information
    Table 134. Exir Description and Major Businesses
    Table 135. Exir Human Insulin Drugs And Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 136. Exir Human Insulin Drugs And Delivery Devices Product Model Numbers, Pictures, Descriptions and Specifications
    Table 137. Exir Recent Developments
    Table 138. Medtronic Corporation Information
    Table 139. Medtronic Description and Major Businesses
    Table 140. Medtronic Human Insulin Drugs And Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 141. Medtronic Human Insulin Drugs And Delivery Devices Product Model Numbers, Pictures, Descriptions and Specifications
    Table 142. Medtronic Recent Developments
    Table 143. Insulet Corporation Information
    Table 144. Insulet Description and Major Businesses
    Table 145. Insulet Human Insulin Drugs And Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 146. Insulet Human Insulin Drugs And Delivery Devices Product Model Numbers, Pictures, Descriptions and Specifications
    Table 147. Insulet Recent Developments
    Table 148. Ypsomed Corporation Information
    Table 149. Ypsomed Description and Major Businesses
    Table 150. Ypsomed Human Insulin Drugs And Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 151. Ypsomed Human Insulin Drugs And Delivery Devices Product Model Numbers, Pictures, Descriptions and Specifications
    Table 152. Ypsomed Recent Developments
    Table 153. Becton Dickinson Corporation Information
    Table 154. Becton Dickinson Description and Major Businesses
    Table 155. Becton Dickinson Human Insulin Drugs And Delivery Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 156. Becton Dickinson Human Insulin Drugs And Delivery Devices Product Model Numbers, Pictures, Descriptions and Specifications
    Table 157. Becton Dickinson Recent Developments
    Table 158. Key Raw Materials Lists
    Table 159. Raw Materials Key Suppliers Lists
    Table 160. Human Insulin Drugs And Delivery Devices Distributors List
    Table 161. Human Insulin Drugs And Delivery Devices Customers List
    Table 162. Human Insulin Drugs And Delivery Devices Market Trends
    Table 163. Human Insulin Drugs And Delivery Devices Market Drivers
    Table 164. Human Insulin Drugs And Delivery Devices Market Challenges
    Table 165. Human Insulin Drugs And Delivery Devices Market Restraints
    Table 166. Research Programs/Design for This Report
    Table 167. Key Data Information from Secondary Sources
    Table 168. Key Data Information from Primary Sources
List of Figures
    Figure 1. Human Insulin Drugs And Delivery Devices Product Picture
    Figure 3. Global Human Insulin Drugs And Delivery Devices Market Share by Type in 2021 & 2028
    Figure 3. Insulin Pumps Product Picture
    Figure 4. Insulin Pens Product Picture
    Figure 5. Insulin Syringes Product Picture
    Figure 6. Basal or Long Acting Insulins Product Picture
    Figure 7. Bolus or Fast-Acting Insulins Product Picture
    Figure 8. Global Human Insulin Drugs And Delivery Devices Market Share by Application in 2021 & 2028
    Figure 9. Hospital
    Figure 10. Household
    Figure 11. Human Insulin Drugs And Delivery Devices Report Years Considered
    Figure 12. Global Human Insulin Drugs And Delivery Devices Sales 2017-2028 (K Units)
    Figure 13. Global Human Insulin Drugs And Delivery Devices Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 14. Global Human Insulin Drugs And Delivery Devices Revenue 2017-2028 (US$ Million)
    Figure 15. Global Human Insulin Drugs And Delivery Devices Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 16. Global Human Insulin Drugs And Delivery Devices Sales Market Share by Region (2017-2022)
    Figure 17. Global Human Insulin Drugs And Delivery Devices Sales Market Share by Region (2023-2028)
    Figure 18. North America Human Insulin Drugs And Delivery Devices Sales YoY (2017-2028) & (K Units)
    Figure 19. North America Human Insulin Drugs And Delivery Devices Revenue YoY (2017-2028) & (US$ Million)
    Figure 20. Europe Human Insulin Drugs And Delivery Devices Sales YoY (2017-2028) & (K Units)
    Figure 21. Europe Human Insulin Drugs And Delivery Devices Revenue YoY (2017-2028) & (US$ Million)
    Figure 22. Asia-Pacific Human Insulin Drugs And Delivery Devices Sales YoY (2017-2028) & (K Units)
    Figure 23. Asia-Pacific Human Insulin Drugs And Delivery Devices Revenue YoY (2017-2028) & (US$ Million)
    Figure 24. Latin America Human Insulin Drugs And Delivery Devices Sales YoY (2017-2028) & (K Units)
    Figure 25. Latin America Human Insulin Drugs And Delivery Devices Revenue YoY (2017-2028) & (US$ Million)
    Figure 26. Middle East & Africa Human Insulin Drugs And Delivery Devices Sales YoY (2017-2028) & (K Units)
    Figure 27. Middle East & Africa Human Insulin Drugs And Delivery Devices Revenue YoY (2017-2028) & (US$ Million)
    Figure 28. The Human Insulin Drugs And Delivery Devices Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 29. The Top 5 and 10 Largest Manufacturers of Human Insulin Drugs And Delivery Devices in the World: Market Share by Human Insulin Drugs And Delivery Devices Revenue in 2021
    Figure 30. Global Human Insulin Drugs And Delivery Devices Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 31. Global Human Insulin Drugs And Delivery Devices Sales Market Share by Type (2017-2028)
    Figure 32. Global Human Insulin Drugs And Delivery Devices Revenue Market Share by Type (2017-2028)
    Figure 33. Global Human Insulin Drugs And Delivery Devices Sales Market Share by Application (2017-2028)
    Figure 34. Global Human Insulin Drugs And Delivery Devices Revenue Market Share by Application (2017-2028)
    Figure 35. North America Human Insulin Drugs And Delivery Devices Sales Market Share by Type (2017-2028)
    Figure 36. North America Human Insulin Drugs And Delivery Devices Revenue Market Share by Type (2017-2028)
    Figure 37. North America Human Insulin Drugs And Delivery Devices Sales Market Share by Application (2017-2028)
    Figure 38. North America Human Insulin Drugs And Delivery Devices Revenue Market Share by Application (2017-2028)
    Figure 39. North America Human Insulin Drugs And Delivery Devices Sales Share by Country (2017-2028)
    Figure 40. North America Human Insulin Drugs And Delivery Devices Revenue Share by Country (2017-2028)
    Figure 41. U.S. Human Insulin Drugs And Delivery Devices Revenue (2017-2028) & (US$ Million)
    Figure 42. Canada Human Insulin Drugs And Delivery Devices Revenue (2017-2028) & (US$ Million)
    Figure 43. Europe Human Insulin Drugs And Delivery Devices Sales Market Share by Type (2017-2028)
    Figure 44. Europe Human Insulin Drugs And Delivery Devices Revenue Market Share by Type (2017-2028)
    Figure 45. Europe Human Insulin Drugs And Delivery Devices Sales Market Share by Application (2017-2028)
    Figure 46. Europe Human Insulin Drugs And Delivery Devices Revenue Market Share by Application (2017-2028)
    Figure 47. Europe Human Insulin Drugs And Delivery Devices Sales Share by Country (2017-2028)
    Figure 48. Europe Human Insulin Drugs And Delivery Devices Revenue Share by Country (2017-2028)
    Figure 49. Germany Human Insulin Drugs And Delivery Devices Revenue (2017-2028) & (US$ Million)
    Figure 50. France Human Insulin Drugs And Delivery Devices Revenue (2017-2028) & (US$ Million)
    Figure 51. U.K. Human Insulin Drugs And Delivery Devices Revenue (2017-2028) & (US$ Million)
    Figure 52. Italy Human Insulin Drugs And Delivery Devices Revenue (2017-2028) & (US$ Million)
    Figure 53. Russia Human Insulin Drugs And Delivery Devices Revenue (2017-2028) & (US$ Million)
    Figure 54. Asia Pacific Human Insulin Drugs And Delivery Devices Sales Market Share by Type (2017-2028)
    Figure 55. Asia Pacific Human Insulin Drugs And Delivery Devices Revenue Market Share by Type (2017-2028)
    Figure 56. Asia Pacific Human Insulin Drugs And Delivery Devices Sales Market Share by Application (2017-2028)
    Figure 57. Asia Pacific Human Insulin Drugs And Delivery Devices Revenue Market Share by Application (2017-2028)
    Figure 58. Asia Pacific Human Insulin Drugs And Delivery Devices Sales Share by Region (2017-2028)
    Figure 59. Asia Pacific Human Insulin Drugs And Delivery Devices Revenue Share by Region (2017-2028)
    Figure 60. China Human Insulin Drugs And Delivery Devices Revenue (2017-2028) & (US$ Million)
    Figure 61. Japan Human Insulin Drugs And Delivery Devices Revenue (2017-2028) & (US$ Million)
    Figure 62. South Korea Human Insulin Drugs And Delivery Devices Revenue (2017-2028) & (US$ Million)
    Figure 63. India Human Insulin Drugs And Delivery Devices Revenue (2017-2028) & (US$ Million)
    Figure 64. Australia Human Insulin Drugs And Delivery Devices Revenue (2017-2028) & (US$ Million)
    Figure 65. Taiwan Human Insulin Drugs And Delivery Devices Revenue (2017-2028) & (US$ Million)
    Figure 66. Indonesia Human Insulin Drugs And Delivery Devices Revenue (2017-2028) & (US$ Million)
    Figure 67. Thailand Human Insulin Drugs And Delivery Devices Revenue (2017-2028) & (US$ Million)
    Figure 68. Malaysia Human Insulin Drugs And Delivery Devices Revenue (2017-2028) & (US$ Million)
    Figure 69. Philippines Human Insulin Drugs And Delivery Devices Revenue (2017-2028) & (US$ Million)
    Figure 70. Latin America Human Insulin Drugs And Delivery Devices Sales Market Share by Type (2017-2028)
    Figure 71. Latin America Human Insulin Drugs And Delivery Devices Revenue Market Share by Type (2017-2028)
    Figure 72. Latin America Human Insulin Drugs And Delivery Devices Sales Market Share by Application (2017-2028)
    Figure 73. Latin America Human Insulin Drugs And Delivery Devices Revenue Market Share by Application (2017-2028)
    Figure 74. Latin America Human Insulin Drugs And Delivery Devices Sales Share by Country (2017-2028)
    Figure 75. Latin America Human Insulin Drugs And Delivery Devices Revenue Share by Country (2017-2028)
    Figure 76. Mexico Human Insulin Drugs And Delivery Devices Revenue (2017-2028) & (US$ Million)
    Figure 77. Brazil Human Insulin Drugs And Delivery Devices Revenue (2017-2028) & (US$ Million)
    Figure 78. Argentina Human Insulin Drugs And Delivery Devices Revenue (2017-2028) & (US$ Million)
    Figure 79. Middle East and Africa Human Insulin Drugs And Delivery Devices Sales Market Share by Type (2017-2028)
    Figure 80. Middle East and Africa Human Insulin Drugs And Delivery Devices Revenue Market Share by Type (2017-2028)
    Figure 81. Middle East and Africa Human Insulin Drugs And Delivery Devices Sales Market Share by Application (2017-2028)
    Figure 82. Middle East and Africa Human Insulin Drugs And Delivery Devices Revenue Market Share by Application (2017-2028)
    Figure 83. Middle East and Africa Human Insulin Drugs And Delivery Devices Sales Share by Country (2017-2028)
    Figure 84. Middle East and Africa Human Insulin Drugs And Delivery Devices Revenue Share by Country (2017-2028)
    Figure 85. Turkey Human Insulin Drugs And Delivery Devices Revenue (2017-2028) & (US$ Million)
    Figure 86. Saudi Arabia Human Insulin Drugs And Delivery Devices Revenue (2017-2028) & (US$ Million)
    Figure 87. U.A.E Human Insulin Drugs And Delivery Devices Revenue (2017-2028) & (US$ Million)
    Figure 88. Human Insulin Drugs And Delivery Devices Value Chain
    Figure 89. Human Insulin Drugs And Delivery Devices Production Process
    Figure 90. Channels of Distribution
    Figure 91. Distributors Profiles
    Figure 92. Bottom-up and Top-down Approaches for This Report
    Figure 93. Data Triangulation
    Figure 94. Key Executives Interviewed